Journal of Neuroimmune Pharmacology · 2019 · 29 citations · 105 references
Life SciencesNeurobiologyNeuroscienceBehavioral NeuroscienceMolecular NeurobiologyMolecular NeuroscienceAntiretroviral TherapyCannabinoid PharmacologyNeurotransmissionSynaptic TransmissionCannabinoid Receptor ModulationHiv Antiretroviral TherapyHiv-associated Cognitive ImpairmentTransgenic MiceTransgenic Mouse Models
In the era of combined antiretroviral therapy, HIV-1 infected individuals are living longer lives; however, longevity is met with an increasing number of HIV-1 associated neurocognitive disorders (HAND) diagnoses. The transactivator of transcription (Tat) is known to mediate the neurotoxic effects in HAND by acting directly on neurons and also indirectly via its actions on glia. The Go/No-Go (GNG) task was used to examine HAND in the Tat transgenic mouse model. The GNG task involves subjects discriminating between two stimuli sets in order to determine whether or not to inhibit a previously trained response. Data reveal inhibitory control deficits in female Tat(+) mice (p = .048) and an upregulation of cannabinoid type 1 receptors (CB1R) in the infralimbic (IL) cortex in the same female Tat(+) group (p < .05). A significant negative correlation was noted between inhibitory control and IL CB1R expression (r = −.543, p = .045), with CB1R expression predicting 30% of the variance of inhibitory control (R2 = .295, p = .045). Furthermore, there was a significant increase in spontaneous excitatory postsynaptic current (sEPSC) frequencies in Tat(+) compared to Tat(−) mice (p = .008, across sexes). The increase in sEPSC frequency was significantly attenuated by bath application of PF3845, a fatty acid amide hydrolase (FAAH) enzyme inhibitor (p < .001). Overall, the GNG task is a viable measure to assess inhibitory control deficits in Tat transgenic mice and results suggest a potential therapeutic treatment for the observed deficits with drugs which modulate endocannabinoid enzyme activity.
105
NIH Image to ImageJ: 25 years of image analysis
Caroline A Schneider, Wayne Rasband, Kevin W. Eliceiri · Nature Methods · 2012 · 65.2K citations
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Ming‐Xin Tang, Diane M. Jacobs, Yaakov Stern et al. · The Lancet · 1996 · 1.6K citations
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
K Tsou, Sean M. Brown, M.Clara Sañudo-Peña et al. · Neuroscience · 1998 · 1.6K citations
Robert K. Heaton, Donald Franklin, Ronald J. Ellis et al. · Journal of NeuroVirology · 2010 · 1.6K citations · Full text
Medicine, Neurology, Neuroscience +16
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Giovanni Marsicano, Sharon Goodenough, Krisztina Monory et al. · Science · 2003 · 1.2K citations
Medicine, Neuroscience, Pharmacology +17